IceCure
Beyond's analysis on IceCure
Recent news mentioning IceCure
- — IceCure Signs Exclusive Distribution Agreement for ProSense® Cryoablation Systems in the Netherlands
- — West Cancer Center Receives IRB Approval to Commence IceCure's ChoICE Study for Breast Cancer Cryoablation
- — IceCure Medical (ICCM) Q2 2026 Earnings Call Transcript
- — IceCure Highlights Two New Peer-Reviewed Publications Supporting Cryoablation in Breast Cancer Treatment De-Escalation
- — IceCure Medical Ltd Q2 2026 Earnings Call Summary
- — IceCure Reports its Financial Results for the First Half of 2026 with 45% Revenue Growth Year-Over-Year
- — IceCure Medical Adds Adventist Health as U.S. Clinical Site for its Post-Marketing "ChoICE" Study for Low-Risk Breast Cancer Cryoablation Treatment
- — IceCure Medical to Report First Half 2026 Financial and Operating Results on August 12, 2026
- — IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance of ProSense®
- — IceCure Medical Kicks Off its Post-Marketing "ChoICE" Study for the Low-Risk Breast Cancer Treatment at First U.S Clinical Site